S Yamagishi Selected Research

S Yamagishi Research Topics

Disease

19	Atherosclerosis 08/2011 - 01/2003
18	Insulin Resistance 05/2015 - 01/2005
14	Diabetic Nephropathies (Diabetic Nephropathy) 09/2016 - 01/2001
14	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2006 - 01/2002
10	Hypertension (High Blood Pressure) 11/2007 - 01/2005
9	Hyperglycemia 08/2015 - 01/2004
9	Inflammation (Inflammations) 11/2008 - 07/2000
9	Diabetic Angiopathies (Diabetic Angiopathy) 01/2007 - 08/2000
8	Cardiovascular Diseases (Cardiovascular Disease) 08/2008 - 01/2004
7	Type 2 Diabetes Mellitus (MODY) 11/2008 - 01/2002
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2007 - 01/2005
7	Diabetes Mellitus 01/2007 - 01/2005
6	Neoplasm Metastasis (Metastasis) 08/2008 - 03/2003
5	Melanoma (Melanoma, Malignant) 05/2013 - 01/2004
5	Alzheimer Disease (Alzheimer's Disease) 01/2007 - 01/2004
4	Body Weight (Weight, Body) 04/2015 - 01/2002
4	Neoplasms (Cancer) 05/2013 - 03/2003
4	Hepatocellular Carcinoma (Hepatoma) 09/2008 - 12/2006
4	Glucose Intolerance 09/2006 - 01/2005
3	Vascular System Injuries 09/2011 - 12/2006
3	Obesity 03/2011 - 01/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011 - 01/2006
3	Liver Diseases (Liver Disease) 01/2009 - 01/2005
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2007 - 01/2004
3	Dehydration (Water Stress) 01/2007 - 01/2004
2	Albuminuria 08/2015 - 07/2001
2	Dyslipidemias (Dyslipidemia) 05/2015 - 01/2005
2	Infections 01/2015 - 01/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013 - 01/2005
2	Uveitis 01/2008 - 11/2007
2	Necrosis 11/2007 - 11/2006
2	Allergic Rhinitis 03/2007 - 09/2000
2	Fatty Liver 01/2006 - 01/2005
2	Osteoporosis 01/2006 - 01/2005
2	Hypercholesterolemia 01/2006 - 01/2006
2	Myocardial Infarction 01/2005 - 01/2005
2	Disease Progression 01/2005 - 01/2005
1	Corneal Neovascularization 09/2016

Drug/Important Bio-Agent (IBA)

43	Advanced Glycation End ProductsIBA 03/2016 - 08/2000
13	pigment epithelium-derived factorIBA 01/2011 - 01/2002
10	Nifedipine (Adalat)FDA LinkGeneric 11/2007 - 01/2003
9	Proteins (Proteins, Gene)FDA Link 09/2016 - 01/2004
9	Insulin (Novolin)FDA Link 04/2015 - 01/2002
9	1,4-dihydropyridine (dihydropyridine)IBA 11/2007 - 01/2003
8	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 01/2002
8	Telmisartan (Micardis)FDA Link 03/2011 - 01/2005
8	CalciumIBA 11/2007 - 01/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 01/2004
7	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2008 - 02/2003
6	Biomarkers (Surrogate Marker)IBA 05/2015 - 01/2004
6	Retinaldehyde (Retinal)IBA 11/2007 - 01/2002
6	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2007 - 01/2003
5	CytokinesIBA 06/2007 - 01/2004
5	Angiotensin IIIBA 12/2006 - 01/2003
5	CarbohydratesIBA 09/2006 - 01/2005
4	Atorvastatin (Lipitor)FDA Link 05/2015 - 12/2006
4	Metformin (Glucophage)FDA LinkGeneric 05/2013 - 01/2005
4	Nateglinide (Starlix)FDA LinkGeneric 03/2011 - 12/2007
4	Triglycerides (Triacylglycerol)IBA 01/2009 - 01/2005
4	GlyceraldehydeIBA 09/2008 - 01/2002
4	PPAR gammaIBA 03/2008 - 01/2005
4	azelnidipineIBA 11/2006 - 01/2005
4	Glycoside Hydrolase InhibitorsIBA 09/2006 - 01/2005
4	Acarbose FDA LinkGeneric 09/2006 - 01/2005
4	PyridoxamineIBA 01/2006 - 01/2005
3	FructoseIBA 04/2015 - 01/2005
3	LipidsIBA 11/2008 - 01/2006
3	Angiotensin II Type 1 Receptor BlockersIBA 03/2008 - 01/2005
3	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2008 - 01/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2007 - 01/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006 - 01/2006
2	AdipokinesIBA 05/2015 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2013 - 01/2002
2	CholesterolIBA 08/2011 - 01/2006
2	Receptor for Advanced Glycation End ProductsIBA 03/2011 - 03/2011
2	Nonesterified Fatty Acids (NEFA)IBA 09/2010 - 01/2005
2	Glycoproteins (Glycoprotein)IBA 03/2009 - 01/2005
2	Serine (L-Serine)FDA Link 09/2008 - 03/2008
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2007 - 09/2000
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2007 - 12/2006
2	polyolIBA 06/2007 - 04/2003
2	Protein Kinase CIBA 06/2007 - 01/2004
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2007 - 11/2006
2	C-Reactive ProteinIBA 01/2007 - 12/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2007 - 01/2006
2	YM 529IBA 01/2006 - 01/2005
2	Oxidoreductases (Dehydrogenase)IBA 01/2006 - 01/2006
2	LDL CholesterolIBA 01/2006 - 01/2006
2	Coenzyme A (CoA)IBA 01/2006 - 01/2006
2	LigandsIBA 01/2005 - 01/2005
2	MitogensIBA 01/2005 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2005 - 01/2005
1	Peptides (Polypeptides)IBA 09/2016
1	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2016
1	8-Hydroxy-2'-DeoxyguanosineIBA 08/2015
1	empagliflozinIBA 08/2015

Therapy/Procedure

8	Therapeutics 03/2011 - 01/2004
2	Oral Administration 09/2006 - 01/2005
2	Glycemic Control 01/2005 - 01/2004
1	Cautery 09/2016